28bio has launched CNS-3D Inflammatory Organoids, an assay-ready immunocompetent model incorporating neurons, astrocytes, and microglia to simulate human neuroimmune responses. This technology provides developers with a high-fidelity alternative to animal models, enabling precise quantification of how anti-inflammatory candidates affect human cellular networks and tissue integrity before clinical trials. By integrating functional calcium imaging with molecular profiling, tech professionals can now distinguish stimulus-specific phenotypes like microglial versus astrocytic activation to better predict therapeutic success in neurodegenerative disease.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
